FDA Inspection 996920 — Catherine Orrell, M.D.
The FDA completed an inspection of Catherine Orrell, M.D. on Dec 9, 2016 in Cape Town. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 9, 2016
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Cape Town (South Africa)
Additional Details
Clinical Investigator (CI)